ANI Pharmaceuticals Inc (ANIP)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 1,283,700 1,287,380 920,753 914,524 904,422 889,914 859,341 765,224 760,087 739,110 751,334 744,846 771,598 470,454 480,159 463,843 461,190 462,581 465,391 482,232
Total stockholders’ equity US$ in thousands 428,530 430,798 455,760 451,963 432,749 454,711 434,472 339,482 338,540 336,675 336,958 346,094 358,740 191,403 191,917 203,712 195,700 195,100 191,344 201,171
Financial leverage ratio 3.00 2.99 2.02 2.02 2.09 1.96 1.98 2.25 2.25 2.20 2.23 2.15 2.15 2.46 2.50 2.28 2.36 2.37 2.43 2.40

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,283,700K ÷ $428,530K
= 3.00

The financial leverage ratio of ANI Pharmaceuticals Inc has shown some fluctuations over the years based on the provided data. The ratio measures the company's use of debt to finance its operations and indicates the proportion of debt in its capital structure.

From March 31, 2020, to June 30, 2020, the financial leverage ratio increased slightly from 2.40 to 2.43 before decreasing to 2.37 by September 30, 2020. There was a further decrease to 2.36 by December 31, 2020. The ratio then continued to decline steadily over the next few quarters, reaching its lowest point of 1.96 as of September 30, 2023.

However, starting from December 31, 2023, the financial leverage ratio began to increase again, rising to 2.09 by the end of that quarter and further to 2.02 by March 31, 2024, and June 30, 2024. The ratio then jumped significantly to 2.99 by September 30, 2024, and remained high at 3.00 by December 31, 2024.

Overall, the trend in the financial leverage ratio of ANI Pharmaceuticals Inc indicates periods of fluctuation and volatility in the company's capital structure, with varying levels of debt utilization over the years. Investors and stakeholders may want to closely monitor these changes to assess the company's risk exposure and financial stability.